Congress expands presidential power to direct industry, invest in companies, waive regulations—with

What it does

This bill modernizes the Defense Production Act of 1950 by expanding presidential powers to direct private industry during national emergencies, establishing new financing mechanisms (loans, grants, equity investments, subsidies) to build domestic capacity for critical technologies and minerals, and creating a National Defense Executive Reserve to temporarily employ private-sector experts in federal agencies. It also strengthens foreign investment screening for agricultural land and critical sectors, requires detailed federal agency reporting on supply-chain strategy, and establishes new oversight structures including a Defense Production Act Committee with expanded authority.

Why we flagged it

The bill's core function is to expand and modernize presidential authority to direct private industry toward national defense objectives through financing, equity stakes, and regulatory waivers. It is fundamentally an industrial policy and supply-chain resilience measure, not a simple reauthorization.

What the text implies

• Government equity investments (up to 15% per company) create potential conflicts of interest and moral hazard: companies may lobby for DPA support knowing the government has a financial stake in their success, and the government's incentive to exit positions may conflict with taxpayer interests.
• The 'waiver to expedite procurement' provisions (sections 101(2), 203, 204) allow the President to bypass environmental, labor, and permitting regulations without explicit congressional approval—only reporting requirements apply, creating a regulatory shadow zone.
• The National Defense Executive Reserve allows private-sector employees to serve in federal positions with security clearances and access to classified information, then return to private industry; ethics rules are delegated to OPM rulemaking (not yet written), creating a revolving-door risk.
• Agricultural land screening (section 315) targets four named foreign adversaries (China, North Korea, Russia, Iran) but sunsets when those countries are removed from the foreign-adversary list—creating a perverse incentive to maintain adversary designations to preserve the screening authority.
• The bill grants the Defense Production Act Committee (chaired by the National Security Advisor, with OMB Director as Executive Director) broad discretion over billions in financing and equity investments with only annual reporting to Congress; no prior approval or appropriation is required for individual transactions.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill creates real public benefits: it strengthens supply-chain resilience for defense and medical supplies, requires transparency through detailed reporting and a public dashboard, and establishes guardrails against self-dealing (20% equity cap, conflict-of-interest rules barring officials and their families from receiving assistance). However, it also grants the President sweeping discretionary power to direct private industry, waive regulations, and make equity investments with minimal con

Who stands to gain

• Defense contractors and suppliers (critical technologies, shipbuilding, materials)
• Mining and processing companies (critical minerals)
• Semiconductor manufacturers
• Pharmaceutical and medical-device manufacturers
• Domestic manufacturing firms in energy, transportation, and infrastructure sectors

Named in the bill

Defense Production Act Committee, Department of Defense, Department of Commerce, Department of Homeland Security, Federal Emergency Management Agency, Office of Management and Budget, Office of Personnel Management, Committee on Financial Services (House), Committee on Banking, Housing, and Urban Affairs (Senate), Secretary of Treasury, Secretary of Agriculture, National Security Advisor — and 1 more

Where it stands

4 cosponsors: 2 Democrats, 2 Republicans.

• Feb 25, 2026 — Introduced · Congress.gov: “Introduced in House”
• Feb 25, 2026 — Referred to House Committee on Financial Services · Congress.gov: “Referred to the House Committee on Financial Services”
• Mar 4, 2026 — Markup held in committee · Congress.gov: “Committee Consideration and Mark-up Session Held”
• Mar 4, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported by the Yeas and Nays: 41 - 0”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 8 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $994,824 in lobbying spend. A filing names 6 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Warren Davidson, the sponsor, reported $281,400 in PAC receipts in the 2026 cycle.

• Earthjustice Action — $376,600 on 2 filings
• Mp Materials Corp. — $230,000 on 1 filing
• National Parks Conservation Association — $150,724 on 1 filing
• Smithfield Foods, Inc. — $120,000 on 1 filing
• American Defense International on Behalf of Mp Materials — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.